Clinical Trial Update: A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma [EARLY_Phase 1]

View source ↗

Summary

SZ1003 injection is being studied in an early-phase trial for advanced hepatocellular carcinoma, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SZ1003 injection (SZ1003)

Snippet

Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. | Conditions: Advanced Hepatocellular Carcinoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING